Prior studies have shown that the breadth of the T cell landscape in NSCLC is closely tied with tumor mutational burden, marked by an increased proportion of dysfunctional CD8+ and CD4+ T cell subsets (72). The gene discussed is CD4; the disease is neoplasm.